HIV and the kidney

Current Infectious Disease Reports

Volumn 11, Issue 6, 2009, Pages 479-485

  Kalayjian, Robert C ^a   Bruggeman, Leslie A ^b   Bark, Charles ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ALPHA INTERFERON; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIRETROVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDINAVIR; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 6; NEF PROTEIN; NEVIRAPINE; PREDNISONE; T LYMPHOCYTE RECEPTOR; TENOFOVIR; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS RNA; VPR PROTEIN;

ACUTE KIDNEY FAILURE; ANTIGEN ANTIBODY COMPLEX; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DOSAGE SCHEDULE COMPARISON; DRUG EXPOSURE; DRUG INTERMITTENT THERAPY; DRUG SAFETY; FANCONI RENOTUBULAR SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PREVALENCE; PROTEIN EXPRESSION; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; VIRUS PATHOGENESIS;

EID: 70449484470     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-009-0069-4     Document Type: Review

References (60)

1. L.I. Gardner S.D. Holmberg J. Moore, et al. 2002 Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care J Acquir Immune Defic Syndr 29 69 75 11782593
2. L.A. Szczech D.R. Hoover J.G. Feldman, et al. 2004 Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy Clin Infect Dis 39 1199 1206 10.1086/424013 15486845 (Pubitemid 40169320)
3. C.M. Wyatt R.R. Arons P.E. Klotman, et al. 2006 Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality AIDS 20 561 565 10.1097/01.aids.0000210610.52836.07 16470120 (Pubitemid 43731600)
4. L.B. Mulenga G. Kruse S. Lakhi, et al. 2008 Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia AIDS 22 1821 1827 10.1097/QAD.0b013e328307a051 18753939
5. Wools-Kaloustian K, On G'or WO, Wafula S, et al.: The relationships between renal dysfunction and clinical outcomes in HIV-infected Kenyans not requiring immediate ART [abstract 741]. Programs and Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; February 8-11, 2009. Available at http://www.retroconference.org. Accessed February 2009.
6. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266.
7. M.C. Odden R. Scherzer P. Bacchetti, et al. 2007 Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study Arch Intern Med 167 2213 2219 10.1001/archinte.167.20.2213 1:CAS:528:DC%2BD2sXhsVansr%2FE 17998494 (Pubitemid 350106741)
8. Vrouenraets S, Garcia E, Brinkman K, et al.: A comparison between different GFR-estimations and [125I]-iothalamate, the gold standard for GFR-measurement, in HIV-infected patients on HAART [abstract 977b]. Programs and Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3-6, 2008. Available at http://www.retroconference.org. Accessed February 2009.
9. N. Franceschini S. Napravnik J.J. Eron Jr, et al. 2005 Incidence and etiology of acute renal failure among ambulatory HIV-infected patients Kidney Int 67 1526 1531 10.1111/j.1523-1755.2005.00232.x 15780107 (Pubitemid 40463131)
10. C. Salliot I. Guichard E. Daugas, et al. 2008 Acute kidney disease due to immune reconstitution inflammatory syndrome in an HIV-infected patient with tuberculosis J Int Assoc Physicians AIDS Care (Chic Ill) 7 178 181 10.1177/1545109708320683
11. A. Mocroft O. Kirk J. Gatell, et al. 2007 Chronic renal failure among HIV-1-infected patients AIDS 21 1119 1127 10.1097/QAD.0b013e3280f774ee 17502722 (Pubitemid 46763282)
12. C.M. Wyatt J.A. Winston C.D. Malvestutto, et al. 2007 Chronic kidney disease in HIV infection: an urban epidemic AIDS 21 2101 2103 10.1097/QAD.0b013e3282ef1bb4 17885301 (Pubitemid 47462160)
13. G.M. Lucas S.H. Mehta M.G. Atta, et al. 2007 End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 AIDS 21 2435 2443 10.1097/QAD.0b013e32827038ad 18025880 (Pubitemid 350145175)
14. G.M. Lucas B. Lau M.G. Atta, et al. 2008 Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races J Infect Dis 197 1548 1557 10.1086/587994 18422458 (Pubitemid 351706485)
15. A. Reid W. Stohr A.S. Walker, et al. 2008 Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy Clin Infect Dis 46 1271 1281 10.1086/533468 18444867 (Pubitemid 351589914)
16. L. Rey A. Viciana P. Ruiz 1995 Immunopathological characteristics of in situ T-cell subpopulations in human immunodeficiency virus-associated nephropathy Hum Pathol 26 408 415 10.1016/0046-8177(95)90142-6 1:STN:280:DyaK2M3itVyqtw%3D%3D 7705820
17. J.B. Kopp M.W. Smith G.W. Nelson, et al. 2008 MYH9 is a majoreffect risk gene for focal segmental glomerulosclerosis Nat Genet 40 1175 1184 10.1038/ng.226 1:CAS:528:DC%2BD1cXhtFKht77E 18794856
18. W.H. Kao M.J. Klag L.A. Meoni, et al. 2008 MYH9 is associated with nondiabetic end-stage renal disease in African Americans Nat Genet 40 1185 1192 10.1038/ng.232 1:CAS:528:DC%2BD1cXhtFKht73O 18794854
19. K. Kiryluk J. Martino A.G. Gharavi 2007 Genetic susceptibility, HIV infection, and the kidney Clin J Am Soc Nephrol 2 Suppl1 S25 S35 10.2215/CJN.00320107 1:CAS:528:DC%2BD2sXosVejtr4%3D 17699508
20. S.D. Cohen P.L. Kimmel 2008 Immune complex renal disease and human immunodeficiency virus infection Semin Nephrol 28 535 544 10.1016/j.semnephrol. 2008.08.006 19013324
21. T.I. de Silva F.A. Post M.D. Griffin, et al. 2007 HIV-1 infection and the kidney: an evolving challenge in HIV medicine Mayo Clin Proc 82 1103 1116 10.4065/82.9.1103 17803878
22. N.J. Weiner J.W. Goodman P.L. Kimmel 2003 The HIV-associated renal diseases: current insight into pathogenesis and treatment Kidney Int 63 1618 1631 10.1046/j.1523-1755.2003.00901.x 12675837 (Pubitemid 36513307)
23. D.M. Fine A.B. Fogo C.E. Alpers 2008 Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient Semin Nephrol 28 545 555 10.1016/j.semnephrol.2008.08.007 19013325
24. L.A. Szczech S.K. Gupta R. Habash, et al. 2004 The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection Kidney Int 66 1145 1152 10.1111/j.1523-1755.2004.00865.x 15327410 (Pubitemid 39121021)
25. T.M. Han S. Naicker P.K. Ramdial, et al. 2006 A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa Kidney Int 69 2243 2250 10.1038/sj.ki.5000339 1:STN:280:DC%2BD28zkslSqtA%3D%3D 16672914 (Pubitemid 43882112)
26. L.A. Bruggeman S. Dikman C. Meng, et al. 1997 Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression J Clin Invest 100 84 92 10.1172/JCI119525 1:CAS:528:DyaK2sXksVOiu70%3D 9202060
27. J. Zhong Y. Zuo J. Ma, et al. 2005 Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy Kidney Int 68 1048 1060 10.1111/j.1523-1755.2005.00497.x 1:CAS:528:DC%2BD2MXhtVCjt7zJ 16105035 (Pubitemid 43246421)
28. A.H. Cohen N.C. Sun P. Shapshak, et al. 1989 Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy Mod Pathol 2 125 128 1:STN:280:DyaL1M3msVCgsQ%3D%3D 2657719
29. P.L. Kimmel T.M. Phillips A. Ferreira-Centeno, et al. 1993 HIV-associated immune-mediated renal disease Kidney Int 44 1327 1340 10.1038/ki.1993.386 1:STN:280:DyaK2c7jtlGnsA%3D%3D 8301934
30. L.A. Bruggeman M.D. Ross N. Tanji, et al. 2000 Renal epithelium is a previously unrecognized site of HIV-1 infection J Am Soc Nephrol 11 2079 2087 1:STN:280:DC%2BD3crgslaktQ%3D%3D 11053484
31. D. Marras L.A. Bruggeman F. Gao, et al. 2002 Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy Nat Med 8 522 526 10.1038/nm0502-522 1:CAS:528:DC%2BD38Xjt1Kgurs%3D 11984599 (Pubitemid 34546757)
32. M. Husain V.D. D'Agati J.C. He, et al. 2005 HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN AIDS 19 1975 1980 10.1097/01.aids.0000191918.42110.27 1:CAS:528:DC%2BD2MXhtFKmsb%2FK 16260903
33. T.C. Lu J.C. He Z.H. Wang, et al. 2008 HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein J Biol Chem 283 8173 8182 10.1074/jbc.M708920200 1:CAS:528:DC%2BD1cXjsFChu7Y%3D 18234668
34. K. Schwarz M. Simons J. Reiser, et al. 2001 Podocin, a raftassociated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin J Clin Invest 108 1621 1629 1:CAS:528:DC%2BD3MXovVCgs7g%3D 11733557
35. M. Sunamoto M. Husain J.C. He, et al. 2003 Critical role for Nef in HIV-1-induced podocyte dedifferentiation Kidney Int 64 1695 1701 10.1046/j.1523-1755.2003.00283.x 1:CAS:528:DC%2BD3sXpsVCrtrk%3D 14531802 (Pubitemid 37323698)
36. J.C. He M. Husain M. Sunamoto, et al. 2004 Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways J Clin Invest 114 643 651 1:CAS:528:DC%2BD2cXnsVemtrY%3D 15343382
37. S. Martinka L.A. Bruggeman 2006 Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy Am J Physiol Renal Physiol 290 F657 F665 10.1152/ajprenal.00208.2005 1:CAS:528: DC%2BD28XjtFCntro%3D 16204413 (Pubitemid 43724968)
38. M.J. Ross S. Martinka V.D. D'Agati, et al. 2005 NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy J Am Soc Nephrol 16 2403 2411 10.1681/ASN.2004121101 1:CAS:528:DC%2BD2MXovVOku70%3D 15975999 (Pubitemid 41725058)
39. M.S. Hayden S. Ghosh 2008 Shared principles in NF-kappaB signaling Cell 132 344 362 10.1016/j.cell.2008.01.020 1:CAS:528:DC%2BD1cXivVahtbY%3D 18267068 (Pubitemid 351192002)
40. J.M. Brenchley D.A. Price T.W. Schacker, et al. 2006 Microbial translocation is a cause of systemic immune activation in chronic HIV infection Nat Med 12 1365 1371 10.1038/nm1511 1:CAS:528:DC%2BD28Xht1OntbnK 17115046 (Pubitemid 44924494)
41. S. Baenziger M. Heikenwalder P. Johansen, et al. 2009 Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology Blood 113 377 388 10.1182/blood-2008-04-151712 1:CAS:528:DC%2BD1MXptFSiug%3D%3D 18824599
42. J.N. Mandl A.P. Barry T.H. Vanderford, et al. 2008 Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections Nat Med 14 1077 1087 10.1038/nm.1871 1:CAS:528:DC%2BD1cXht1Slu7vF 18806803
43. M. Albaqumi T.J. Soos L. Barisoni, et al. 2006 Collapsing glomerulopathy J Am Soc Nephrol 17 2854 2863 10.1681/ASN.2006030225 1:CAS:528: DC%2BD28XhtFWksb7F 16914539 (Pubitemid 44484675)
44. M.J. Ross C. Fan M.D. Ross, et al. 2006 HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells J Acquir Immune Defic Syndr 42 1 11 10.1097/01.qai.0000218353.60099.4f 1:CAS:528: DC%2BD28XlsFGqtr0%3D 16763488 (Pubitemid 43947940)
45. M.P. O'Donnell C.C. Chao G. Gekker, et al. 1998 Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes Kidney Int 53 593 597 10.1046/j.1523-1755.1998.00789.x 9507203 (Pubitemid 28124272)
46. L.H. Kuller R. Tracy W. Belloso, et al. 2008 Inflammatory and coagulation biomarkers and mortality in patients with HIV infection PLoS Med 5 e203 10.1371/journal.pmed.0050203 18942885
47. G. Herbein K.A. Khan 2008 Is HIV infection a TNF receptor signalling-driven disease? Trends Immunol 29 61 67 10.1016/j.it.2007.10.008 1:CAS:528:DC%2BD1cXhslGitL0%3D 18178131
48. G.M. Lucas J.A. Eustace S. Sozio, et al. 2004 Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study AIDS 18 541 546 10.1097/00002030-200402200-00022 15090808 (Pubitemid 38365883)
49. C.S. Krawczyk S.D. Holmberg A.C. Moorman, et al. 2004 Factors associated with chronic renal failure in HIV-infected ambulatory patients AIDS 18 2171 2178 10.1097/00002030-200411050-00009 15577650 (Pubitemid 39463682)
50. W.M. El-Sadr J.D. Lundgren J.D. Neaton, et al. 2006 CD4+ countguided interruption of antiretroviral treatment N Engl J Med 355 2283 2296 10.1056/NEJMoa062360 1:STN:280:DC%2BD28npvVSntw%3D%3D 17135583 (Pubitemid 44837777)
51. A. Mocroft C. Wyatt L. Szczech, et al. 2009 Interruption of antiretroviral therapy is associated with increased plasma cystatin C AIDS 23 71 82 10.1097/QAD.0b013e32831cc129 1:CAS:528:DC%2BD1cXhsVCrsL7F 19050388
52. Beversluis D, Reynolds S, Kityo C, et al.: Greater renal function preservation is associated with continuous vs intermittent ART [abstract 742]. Programs and Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; February 8-11, 2009. Available at http://www.retroconference.org. Accessed February 2009.
53. R.C. Kalayjian N. Franceschini S.K. Gupta, et al. 2008 Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease AIDS 22 481 487 10.1097/QAD.0b013e3282f4706d 1:CAS:528:DC%2BD1cXisVeltb4%3D 18301060 (Pubitemid 351317289)
54. P.J. Peters D.M. Moore J. Mermin, et al. 2008 Antiretroviral therapy improves renal function among HIV-infected Ugandans Kidney Int 74 925 929 10.1038/ki.2008.305 1:CAS:528:DC%2BD1cXhtFWhtrbP 18614998
55. A. Karras M. Lafaurie A. Furco, et al. 2003 Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus Clin Infect Dis 36 1070 1073 10.1086/368314 12684922 (Pubitemid 36513295)
56. R. Jones J. Stebbing M. Nelson, et al. 2004 Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study J Acquir Immune Defic Syndr 37 1489 1495 10.1097/01.qai.0000138983.45235.02 1:CAS:528:DC%2BD2MXhtlSiuw%3D%3D 15602127 (Pubitemid 39602339)
57. J.E. Gallant J.A. Winston E. DeJesus, et al. 2008 The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients AIDS 22 2155 2163 10.1097/QAD.0b013e3283112b8e 1:CAS:528:DC%2BD1cXhtF2jsrbF 18832879
58. J. Tourret I. Tostivint S. Tezenas Du Montcel, et al. 2007 Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis Clin Infect Dis 45 779 784 10.1086/521168 17712764 (Pubitemid 47378893)
59. J. Winston G. Deray T. Hawkins, et al. 2008 Kidney disease in patients with HIV infection and AIDS Clin Infect Dis 47 1449 1457 10.1086/593099 18947327
60. S.K. Gupta J.A. Eustace J.A. Winston, et al. 2005 Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America Clin Infect Dis 40 1559 1585 10.1086/430257 15889353 (Pubitemid 40720806)